Featured Research

from universities, journals, and other organizations

No healing in a vacuum, study finds

Date:
June 17, 2011
Source:
Deutsches Aerzteblatt International
Summary:
Negative-pressure wound therapy probably does not promote healing, according to a recent meta-analysis of controlled trials.

Negative-pressure wound therapy probably does not promote healing. This is the conclusion of Frank Peinemann and Stefan Sauerland's meta-analysis in the current edition of Deutsches Ärzteblatt International.

In negative-pressure wound therapy (NPWT), wounds are covered with an airtight film and an adjustable negative pressure is applied using an electronically controlled pump. The negative pressure drains wound exudate and is thought to promote healing. This procedure is used in particular for chronic persistent wounds and complicated wounds.

The research included a total of 21 randomized controlled trials that reported on commercially available NPWT systems and systems not commercially available. The proportion of patients with complete wound closure was reported in only five trials, and only two showed a statistically significant effect in favor of NPWT. The results on complete wound closure are not homogenous, and as yet it cannot be concluded that NPWT is superior to the control treatment.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Frank Peinemann, Stefan Sauerland. Negative-Pressure Wound Therapy: Systematic Review of Randomized Controlled Trials. Deutsches Ärzteblatt International, 2011; 108 (22): 381-9 DOI: 10.3238/arztebl.2011.0381

Cite This Page:

Deutsches Aerzteblatt International. "No healing in a vacuum, study finds." ScienceDaily. ScienceDaily, 17 June 2011. <www.sciencedaily.com/releases/2011/06/110617081157.htm>.
Deutsches Aerzteblatt International. (2011, June 17). No healing in a vacuum, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/06/110617081157.htm
Deutsches Aerzteblatt International. "No healing in a vacuum, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/06/110617081157.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins